FDA Issues Warning Letter to IBSPOT.com
November 12, 2025
November 12, 2025
WASHINGTON, Nov. 12 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to IBSPOT.com Inc. from the Center for Drug Evaluation and Research:
* * *
Recipient: Danielle White, President, IBSPOT.com Inc., 1414 Willow Avenue, Elkins Park, PA 19027, United States, support@ibspot.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
* * *
Recipient: Danielle White, President, IBSPOT.com Inc., 1414 Willow Avenue, Elkins Park, PA 19027, United States, support@ibspot.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
